Local media: UC, UC Health to examine potential COVID-19 treatment
In the absence of an approved treatment for COVID-19, in March the FDA began allowing researchers to request emergency authorization for the use of convalescent plasma which shows potential as a treatment for the disease.
Researchers at the UC College of Medicine are among those who joined the Mayo Clinic protocol for investigating convalescent plasma as a possible treatment for COVID-19. Convalescent plasma is obtained from people who have recovered from COVID-19 and have been free of symptoms for 28 days. This program may allow access to that plasma for hospitalized patients infected with the novel coronavirus who have severe or life-threatening COVID-19, or who may be at high risk for progression to severe or life-threatening disease.
This research garnered coverage from the Cincinnati Business Courier, Cincinnati Enquirer, WLWT, Fox19 and WVXU.
Featured image at top from freestocks on Unsplash.
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
Styrene and its health, environmental impacts
September 25, 2024
A chemical leak from a train car in Hamilton County led to evacuations. UC experts are sharing what is styrene and offer a look at the health and environmental impacts.
How to use monoclonal antibodies for migraine in primary care
September 25, 2024
The University of Cincinnati's Vincent Martin told Medscape that every primary care clinician should know about monoclonal antibodies for preventing migraines that are changing the lives of patients.
Fall can be prime time of year for sinus suffering
September 24, 2024
The fall season can be a prime time of year for sinus suffering, but Ahmad Sedaghat, MD, PhD, FACS, said it doesn't have to be that way. He is a professor of otolaryngology in the UC College of Medicine. He is also director of the division of rhinology, allergy and anterior skull base surgery. Sedaghat is an internationally recognized expert on chronic rhinosinusitis and allergies.